{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:06:25Z","timestamp":1791245185013,"version":"4.1.0"},"reference-count":127,"publisher":"Informa UK Limited","issue":"7","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Cancer Investigation"],"published-print":{"date-parts":[[2026,8,9]]},"DOI":"10.1080\/07357907.2026.2672753","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T11:41:44Z","timestamp":1779104504000},"page":"801-824","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Current Landscape of Anti-HER2 Targeted Therapy in Breast Cancer: Challenges and Future Perspectives"],"prefix":"10.1080","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0460-0916","authenticated-orcid":false,"given":"Pooja","family":"Bharali","sequence":"first","affiliation":[{"name":"National Institute of Biologicals, Ministry of Health & Family Welfare","place":["Noida, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9523-3928","authenticated-orcid":false,"given":"Vikrant","family":"Mehta","sequence":"additional","affiliation":[{"name":"Lester and Sue Smith Breast Center, Baylor College of Medicine","place":["Houston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1440-6875","authenticated-orcid":false,"given":"Subhash","family":"Chand","sequence":"additional","affiliation":[{"name":"National Institute of Biologicals, Ministry of Health & Family Welfare","place":["Noida, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9286-8613","authenticated-orcid":false,"given":"Harish","family":"Chander","sequence":"additional","affiliation":[{"name":"National Institute of Biologicals, Ministry of Health & Family Welfare","place":["Noida, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"e_1_3_5_2_1","unstructured":"Breast cancer [Internet]. World Health Organization. [cited 2025 Jul 31]. Available from https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/breast-cancer."},{"key":"e_1_3_5_3_1","unstructured":"Breast cancer [Internet]. 2024. cited 2025 Jul 31. Available from: https:\/\/www.europadonna.org\/breast-cancer\/."},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17122095"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1615\/critrevoncog.v5.i2-3.100"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.3798106"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.12.5321"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-019-0069-2"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.2174\/1568011053174846"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.22.00519"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/genes13112065"},{"issue":"3","key":"e_1_3_5_12_1","first-page":"S100","article-title":"Circumventing de novo and acquired resistance to trastuzumab: new hope for the care of ErbB2-positive breast cancer","volume":"8","author":"HERCEPTIN:(trastuzumab) Label","year":"2008","unstructured":"HERCEPTIN:(trastuzumab) Label. Circumventing de novo and acquired resistance to trastuzumab: new hope for the care of ErbB2-positive breast cancer. Clin Breast Cancer. 2008;8(Suppl 3):S100\u2013S113. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/103792s5250lbl.pdfPiccart M2008.","journal-title":"Clin Breast Cancer"},{"key":"e_1_3_5_13_1","unstructured":"T S S O. Monoclonal antibodies market by source (murine chimeric humanized and human) indication (cancer autoimmune diseases inflammatory diseases infectious diseases and others) and end user (hospitals research institutes and others): global opportunity analysis and industry Forecast 2021-2030. alliedmarketresearch."},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2009.22.1507"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2001.28544"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61964-4"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32616-2"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1113216"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-016-3851-7"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30312-1"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2021"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-022-00579-0"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.4137\/CMO.S6460"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejm200103153441101"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1389390"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01455"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-021-06280-x"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1159\/000346837"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(13)70130-x"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)00163-7"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1703643"},{"issue":"2","key":"e_1_3_5_33_1","article-title":"Adjuvant pertuzumab or placebo\u2009+\u2009trastuzumab\u2009+\u2009chemotherapy in patients with early HER2-positive operable breast cancer in APHINITY: final analysis at 11.3 years\u2019 median follow-up","volume":"34","author":"Loibl S","year":"2023","unstructured":"Loibl S, Piccart M, Clark E, Viale G, Caballero C, Henry C, et al. Adjuvant pertuzumab or placebo\u2009+\u2009trastuzumab\u2009+\u2009chemotherapy in patients with early HER2-positive operable breast cancer in APHINITY: final analysis at 11.3 years\u2019 median follow-up. Ann Oncol. 2023;34(Suppl_2) LBA1","journal-title":"Ann Oncol"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3069"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.7932"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2021.08.007"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.21.02937"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1419246"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1158\/00085472.can-08-1776"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2406070"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1814017"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2115022"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2203690"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2025.10.019"},{"key":"e_1_3_5_45_1","article-title":"Trastuzumab deruxtecan alone or in combination with anastrozole for the treatment of early stage HER2-low, hormone receptor\u2013positive breast cancer","author":"Jonsson Comprehensive Cancer Center","year":"2025","unstructured":"Jonsson Comprehensive Cancer Center Trastuzumab deruxtecan alone or in combination with anastrozole for the treatment of early stage HER2-low, hormone receptor\u2013positive breast cancer. ClinicalTrials.gov. 2025; Identifier: NCT04553770 Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04553770","journal-title":"ClinicalTrials.gov"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.21037\/tbcr-25-35"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.101613"},{"key":"e_1_3_5_48_1","unstructured":"Syd985 ([vic-]trastuzumab duocarmazine): What is it and is it FDA approved? [Internet]. [cited 2025 Jul 31]. Available from: https:\/\/www.drugs.com\/history\/syd985.html."},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol29040222"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.08.2088"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30328-6"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1021\/mp500781a"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02488"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra1307118"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1200\/edbk_351222"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.15.88"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-10-3795"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djk134"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-09-0636"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1615\/critrevoncog.v17.i1.20"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2009.25.8707"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2014.55.2158"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.20517\/cdr.2025.26"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-019-1246-2"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-1557"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-019-0635-y"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-025-00868-y"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12030670"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217900"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1093\/abt\/tby003"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.5384"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70336-9"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01204"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.71415"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2022.2121704"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1914510"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.70268"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2006.24.18_suppl.6044"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2021-0546"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33102"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.07.460"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.TARG-21-P201"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-21-1119"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2014.32.15_suppl.651"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-2827"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-015-3503-3"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20051115"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06572-2"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2025.102284"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.591"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.1090"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2019.12.037"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-22-0456"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.1093\/abt\/tbae019"},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.1093"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11905-7"},{"key":"e_1_3_5_97_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019"},{"key":"e_1_3_5_98_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.706606"},{"key":"e_1_3_5_99_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15071987"},{"key":"e_1_3_5_100_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.sabcs15-ot3"},{"key":"e_1_3_5_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470"},{"key":"e_1_3_5_102_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005119"},{"key":"e_1_3_5_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2021.04.011"},{"key":"e_1_3_5_104_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13225771"},{"key":"e_1_3_5_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(20)30112-1"},{"key":"e_1_3_5_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.02.006"},{"key":"e_1_3_5_107_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061573"},{"key":"e_1_3_5_108_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.TPS1101"},{"key":"e_1_3_5_109_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2009.27.8549"},{"key":"e_1_3_5_110_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-018-4852-5"},{"key":"e_1_3_5_111_1","unstructured":"Who prequalifies first biosimilar medicine to increase worldwide access to life-saving breast cancer treatment [Internet]. World Health Organization; [cited 2025 Jul 31]. Available from: https:\/\/www.who.int\/news\/item\/18 12-2019-who-prequalifies-first-biosimilar-medicine-to-increase-worldwide-access-to-life-saving-breast-cancer treatment."},{"key":"e_1_3_5_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2018.01.006"},{"key":"e_1_3_5_113_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2018-0680"},{"key":"e_1_3_5_114_1","doi-asserted-by":"publisher","DOI":"10.1177\/1758835919887044"},{"key":"e_1_3_5_115_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2024.30.10.1160"},{"key":"e_1_3_5_116_1","first-page":"250822","article-title":"Global trastuzumab biosimilar market size, share, trends & industry forecast 2026\u20132034","volume":"150","author":"Verified Market Reports","year":"2025","unstructured":"Verified Market Reports Global trastuzumab biosimilar market size, share, trends & industry forecast 2026\u20132034. Report ID. 2025;150:250822. Available from https:\/\/www.verifiedmarketreports.com\/product\/trastuzumab-biosimilar-market\/","journal-title":"Report ID"},{"key":"e_1_3_5_117_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.76061"},{"key":"e_1_3_5_118_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.34.15_suppl.LBA503"},{"key":"e_1_3_5_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(17)30434-5"},{"key":"e_1_3_5_120_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2017.74.0126"},{"key":"e_1_3_5_121_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09895-5"},{"key":"e_1_3_5_122_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-022-00534-w"},{"key":"e_1_3_5_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.05.025"},{"key":"e_1_3_5_124_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.1002"},{"key":"e_1_3_5_125_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2014.60.0353"},{"key":"e_1_3_5_126_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2022-0045"},{"key":"e_1_3_5_127_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.953641"},{"key":"e_1_3_5_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2025.104955"}],"container-title":["Cancer Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/07357907.2026.2672753","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/07357907.2026.2672753","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/07357907.2026.2672753","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T19:40:36Z","timestamp":1784662836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/07357907.2026.2672753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":127,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,8,9]]}},"alternative-id":["10.1080\/07357907.2026.2672753"],"URL":"https:\/\/doi.org\/10.1080\/07357907.2026.2672753","relation":{},"ISSN":["0735-7907","1532-4192"],"issn-type":[{"value":"0735-7907","type":"print"},{"value":"1532-4192","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icnv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icnv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-08-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}